The FDA and CDC paused use of Johnson & Johnson's COVID-19 vaccine after reports of 6 cases of blood clots. Tuesday (4/13), Dr. Anthony Fauci said: "The pause not only allows us to take a look at the cases and learn more, but it is also a signal out there to help the physicians."
ANTHONY FAUCI: A couple of issues come up of-- of the importance of-- of calling this pause, because people say what does a pause mean? It really allows both the FDA and the CDC to further investigate these cases to try and understand some of the mechanisms of what it is, some more details about the history of the individuals who were involved that might shed some light on looking forward what will happen and what we will do. That's the first thing.
The other thing is to make physicians out there aware of this. And there are some clinical implications of that that I believe are important. For example, if someone comes in with this really rather rare syndrome of thrombotic thrombocytopenia, where you get thrombosis. And when you have thrombosis, the most common way to treat that is with heparin. That would be a mistake in this situation, because it could be dangerous and make the situation much worse.
So there's a clinically relevant reason why you want to make this known to people. Also, when individuals, particularly younger women, who might come into a physician with a particular thrombotic phenomenon, which is things that happen for other reasons all the time, that we want to alert the physicians to take a history of a recent vaccination. That would be important.
So the pause not only allows us to take a look at the cases and learn more. But it is also a signal out there to help the physicians.